🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1 open-label pharmacodynamics study in healthy adults. The ...
Status
Completed
Location
Scintipharma, Inc.
Start Date
2017-03-31
Trial ID
NCT03121339
Treatments Being Tested
Since its first outbreak occurred in 1976, Zaire Ebola virus have been asso...
Status
Completed
Location
Phase 1 vaccine clinical trial center of Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2014-12
Trial ID
NCT02326194
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate S...
Status
Completed
Location
KEMRI/Centre for Respiratory Diseases Research Siaya Clinical Research Annex
Start Date
2023-10-19
Trial ID
NCT05817422
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
The primary purpose of this trial is to determine the safety of XC001 (AdVE...
Status
Completed
Location
Stanford University
Start Date
2020-01-24
Trial ID
NCT04125732
Treatments Being Tested
The primary objective of this phase 1 trial is to determine the dose-depend...
Status
Withdrawn
Location
Henry Ford Health System
Start Date
2017-01-13
Trial ID
NCT03029871
Treatments Being Tested
This is a Phase 1 open-label study to evaluate the safety, tolerability, an...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of China Medical Univeristy
Start Date
2024-05-07
Trial ID
NCT06215846
Treatments Being Tested
An open-labelled, uncontrolled, single-center Phase I/IIa clinical study to...
Status
Active Not Recruiting
Location
Endocrine Oncology Clinic, Uppsala University Hospital
Start Date
2016-03
Trial ID
NCT02749331
Treatments Being Tested
Subjects will receive multiple sub-doses over a 4-hour period to deliver a ...
Status
Completed
Location
AltaSciences LA
Start Date
2022-01-24
Trial ID
NCT05213728
Treatments Being Tested
The objectives of this study is to assess the characteristics and frequency...
Status
Completed
Location
VISSUM
Start Date
2014-07
Trial ID
NCT02254330